A set of emerging diagnostic tools may help identify breast cancer patients who are most likely to benefit from therapies that target important enzymes fueling a range of subtypes, including BCRA-mutated and triple negative ...
Dec 6, 2018
0
3
Researchers from the National Research Nuclear University MEPhI (Russia) have recently developed a new type of contrast agent for magnetic resonance imaging (MRI) based on biodegradable silicon nanoparticles. The method can ...
Oct 1, 2018
0
12
A new study from Uppsala University shows that many patients with colon cancer do not need any chemotherapy and that among patients who benefit from chemotherapy it does not have to be as intense for everyone.
Aug 30, 2018
0
0
Loss of TLK1 and TLK2 results in extensive DNA damage during DNA replication and in cancer cell death. Depletion of TLK1/2 enhances the effectiveness of some chemotherapeutic agents currently being tested in clinical trials
Aug 9, 2018
0
0
As many as one in three women treated for breast cancer undergo unnecessary procedures, but a new method for diagnosing it could do a better job distinguishing between benign and aggressive tumors.
Apr 30, 2018
0
768
Can genes normally expressed only in the eye be activated in brain tumours? The phenomenon, though surprising, has been observed in certain types of medulloblastoma, paediatric tumours of the cerebellum. Researchers from ...
Mar 12, 2018
0
2
Enhancing the diagnosis of breast cancer is the goal of a research team at the German Cancer Research Center (DKFZ) in Heidelberg. The scientists have combined an advanced method of diffusion-weighted MR imaging with intelligent ...
Feb 21, 2018
0
29
Colorectal cancer is one of the most common cancers in the developed world. Although the five-year survival rates for earlier stages of this cancer are relatively high, at later stages, survival drops and the risk of cancer ...
Jan 11, 2018
0
812
Scientists at Dana-Farber Cancer Institute have shown that experimental diabetes drugs can make cancer cells more vulnerable to traditional chemotherapy agents, and they say such combinations should be explored to potentially ...
Jan 2, 2018
0
23
Increasing the dose intensity of chemotherapy by either shortening the intervals between the cycles or by sequential administration instead of concurrent administration of the drugs reduced the risk of early-stage breast ...
Dec 6, 2017
0
1
